Dr. Jay Michael Kashkin, MD

Dr. Kashkin practices at Advocare in Marlton, New Jersey.

Dr. Kashkin's NPI, 1235128497, was assigned on October 19, 2005. Dr. Kashkin graduated from CETEC University Santo Domingo in 1983. Dr. Kashkin's New Jersey license number on file is MA51994.

Dr. Kashkin's primary practice is Advocare, at 401 State Highway 73, Marlton, NJ 08053 in Burlington County. The practice phone is (856) 872-7055.

Dr. Kashkin's primary practice is Advocare in Marlton, New Jersey. Dr. Kashkin is also affiliated with The Valley Hospital. The medical group on file is Advocare. Dmand AI also links Dr. Kashkin to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kashkin practices, 3 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Kashkin's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Kashkin is board certified in american board of pediatrics by the Pediatrics. Dmand AI has Dr. Kashkin's licenses on file in 2 states: New Jersey and Pennsylvania.

Dmand AI lists acid reflux, asthma, chronic nasal allergies, contact dermatitis, ear eustachian tube disorders, hives, itchy rashes and upper respiratory infection (URI) among the conditions Dr. Kashkin treats.

CMS data shows 91 Medicare services from Dr. Kashkin across 3 procedure codes in 2024, all of them office visits, for 91 Medicare patients. Medicare paid $9,614 for them. Every service was in an office.

CMS counts 91 Medicare patients who saw Dr. Kashkin in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 0.84, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kashkin's median patient age at 20, with 46% women.

In 2024, Dr. Kashkin wrote 467 Medicare Part D claims for 82 patients. 54% of them were for generic drugs. CMS names the drug for 312 of them, across 9 drugs with 11 or more claims each, at $4,667,136 in total drug cost. In 2023, CMS named 293 claims across 10 drugs.

Dr. Kashkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kashkin as offering telehealth.

Dmand AI links 6 papers to Dr. Kashkin, published from 2018 to 2021. 2018 was the busiest year, with 2. The most frequent topics are Angioedemas, Hereditary and Complement C1 Inhibitor Protein. Dr. Kashkin's most frequent co-authors are Marc Andrew Riedl, MD, Timothy J. Craig, DO and Douglas Thomas Johnston, DO.

Dmand AI links Dr. Kashkin to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Hereditary Complement Deficiency Diseases, Angioedemas, Hereditary and Angioedema. Open Payments lists research payments to Dr. Kashkin that name 1 trial.

CMS Open Payments shows 1,281 general payments to Dr. Kashkin from 24 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 49% of the total. Shire North American Group Inc paid the most, $357,752. It also lists 32 research payments totaling $53,503 from 2016 to 2021, naming 1 clinical trial.

Dmand AI lists 5 awards for Dr. Kashkin, most recently Super Docs in 2022.

Dr. Kashkin graduated from CETEC University Santo Domingo in 1983. Dr. Kashkin is a member of AAAAI and ACAAI.

Dr. Kashkin is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.